Use of angiotensin i to Ii converting enzyme inhibitor S.Q. 14225 (captopril) , in moderate essential hypertension
Ryan, E.; Muldowney, F.P.
Irish Medical Journal 76(4): 175; 177-178
1983
ISSN/ISBN: 0332-3102 PMID: 6345457 Document Number: 199440
Document emailed within 1 workday
Related Documents
Miyazaki, N.; Shionoiri, H.; Uneda, S.; Yasuda, G.; Gotoh, E.; Fujishima, S.; Kaneko, Y.; Kawahara, Y.; Yamazaki, Y. 1982: Blood concentration and urinary excretion of captopril (SQ 14,255), angiotensin converting enzyme activity and R-A-A system after administration of captopril--in patients with chronic renal failure compared with essential hypertension Nihon Jinzo Gakkai Shi 24(4): 421-428Mizuno, K.; Hashimoto, S.; Kunii, N.; Tani, M.; Niimura, S.; Yabe, R.; Watari, H.; Fukuchi, S. 1985: Acute effects of the new oral angiotensin converting enzyme inhibitor 1-(D-3-acetylthio-2-methylpropanoyl)-L-prolyl-L-phenylalanine (Alacepril) in essential hypertension Research Communications in Chemical Pathology and Pharmacology 49(2): 175-187
Schiffrin, E.L.; Deng, L.Y.; Larochelle, P. 1994: Prospective study of the effects of an angiotensin converting enzyme inhibitor and a beta blockader on the structure and function of resistant arteries in mild essential hypertension Archives des Maladies du Coeur et des Vaisseaux 87(8): 979-981
Antelava, N.A.; Gongadze, N.V.; Gogolauri, M.I.; Kezeli, T.D.; Pachkoriia, K.Z. 2007: Comparative characteristic of angiotensin-converting enzyme inhibitor--captopril and the angiotensin Ii receptor blokers--losartan action on the oxidative metabolism in experimental hyperlipidemia in rabbits Georgian Medical News 150: 57-60
Fagard, R.; Amery, A.; Lijnen, P.; Staessen, J. 1980: First dose effect of the oral angiotensin converting enzyme inhibitor captopril Archives Internationales de Pharmacodynamie et de Therapie Suppl: 178-187
Xin, Z.-h.; Ma, H.-l.; Wu, S.-y.; Dai, C.-h. 2003: Determination of the inhibitory activity of angiotensin-converting enzyme inhibitor captopril by high performance capillary electrophoresis Yao Xue Xue Bao 38(11): 843-845
Soares, G.P.; Romaldini, H.; dos Santos, M.L.; Ratto, O.R. 1989: The role of angiotensin-converting enzyme inhibitor (captopril) on the mechanism of hypoxic pulmonary vasoconstriction. Experimental study in dogs Arquivos Brasileiros de Cardiologia 52(6): 307-314
Aono, J.; Koga, T.; Yamazaki, T.; Shiraki, Y.; Sakai, K. 1988: Antihypertensive action of a novel orally active angiotensin converting enzyme inhibitor altiopril calcium (MC-838) in several hypertensive models of rats: comparison with captopril Archives Internationales de Pharmacodynamie et de Therapie 292: 203-222
Spieker, C.; Zidek, W.; Vetter, H.; Rahn, K.H. 1991: Ambulatory 24-h blood pressure monitoring in essential hypertensives treated with the angiotensin-converting enzyme inhibitor ramipril Journal of International Medical Research 19(1): 39-43
Almazov, V.A.; Ametov, A.S.; Shliakhto, E.V.; Dolgova, I.B.; Pushkarev, A.A. 1989: Neurohumoral mechanisms regulating renal blood circulation in patients with hypertension undergoing captopril block of angiotensin-converting enzyme Terapevticheskii Arkhiv 61(8): 13-15
Stanek, E.J.; Nara, A.R.; Strohl, K.P.; Nair, R.N.; Decker, M.J.; Munger, M.A. 1994: Effect of long-term angiotensin-converting enzyme inhibitor therapy on arterial oxygen saturation in patients with mild to moderate heart failure PharmacoTherapy 14(3): 321-329
Rosolová, H.; Cech, F.; Sefrna, F. 2002: Treatment of hypertension in diabetics with trandolapril, an angiotensin converting enzyme inhibitor--a multicenter study Vnitrni Lekarstvi 48(8): 701-706
Karpov, I.A.; Deev, A.D. 2003: Russian study of efficacy and safety of an angiotensin converting enzyme inhibitor quinapril in patients with hypertension Kardiologiia 43(6): 28-32
Ramirez, A.J.; Migliorini, M.; Gilbert, B.H.; Marco, E.J.; Sanchez, R.A. 1991: Non-modulating essential hypertension: renal hemodynamic effects of long-term angiotensin converting enzyme inhibition Journal of Hypertension. Supplement: Official Journal of the International Society of Hypertension 9(6): S396-S397
Vladkovs'kyĭ, I.K.; Plesh, I.A.; Haĭdukov, V.A.; Loboda, M.I. 1996: The effect of the angiotensin-converting enzyme inhibitor Capoten on the volume-regulation indices of patients with stage-Ii hypertension Likars'ka Sprava 1996(3-4): 113-117
Britov, A.N.; Alamdarova, I.I.; Deev, A.D.; Orlov, A.A. 2003: Special features of clinical effects of an angiotensin converting enzyme inhibitor lisinopril in patients with arterial hypertension Kardiologiia 43(10): 66-71
Kutkuhn, B.; Chlebowski, H.; Hollenbeck, M.; Grabensee, B. 1989: Conversion of inactive renin to active renin following acute angiotensin converting enzyme inhibition in essential hypertension and renovascular hypertension Zeitschrift für Kardiologie 78(3): 204-210
Brazhnik, V.A.; Gorashko, N.M.; Minushkina, L.O.; Zateĭshchikov, D.A.; Zateĭshchikova, A.A.; Nosikov, V.V.; Sidorenko, B.A. 2003: Polymorphic markers I/D and G7831A of angiotensin-I-converting enzyme gene and left ventricular hypertrophy in patients with essential hypertension Kardiologiia 43(2): 44-49
Tajima, J.; Abe, K.; Yasujima, M.; Tanno, M.; Yoshinaga, K. 1984: Effects of 3 different angiotensin converting enzyme inhibitors, MK 421, SQ 14225 and SA 446 on renal function and blood pressure in patients with essential hypertension Nihon Jinzo Gakkai Shi 26(6): 779-789
Katel'nitskaia, L.I.; Ivanchenko, D.N.; Khansheva, L.A.; Kholoshina, L.V.; Glova, S.E.; Pleskachev, S.A. 2006: Advantages of long-term controlled stepwise therapy of arterial hypertension with the use of angiotensin converting enzyme inhibitor spirapril Kardiologiia 46(3): 35-38